CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-22 | HANLY ANN M. EVP & Chief Technology Officer | Grant or award 10b5-1 | +32,500 | 147,076 | ||
| 2024-02-22 | HANLY ANN M. EVP & Chief Technology Officer | Sale 10b5-1 | −12,296 | $10.05 | $124K | 134,780 |
| 2024-02-22 | HANLY ANN M. EVP & Chief Technology Officer | Grant or award · Stock Option (Right to Buy) 10b5-1 | +65,000 | 65,000 | ||
| 2024-02-22 | De Backer Marianne Chief Executive Officer | Grant or award | +175,000 | 751,452 | ||
| 2024-02-22 | De Backer Marianne Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2024-02-22 | Lee Sung EVP & Chief Financial Officer | Grant or award | +40,000 | 106,500 | ||
| 2024-02-22 | Lee Sung EVP & Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2024-02-22 | Pang Phillip EVP & Chief Medical Officer | Sale 10b5-1 | −14,568 | $10.05 | $146K | 250,111 |
| 2024-02-22 | SCANGOS GEORGE A Director | Sale 10b5-1 | −10,028 | $10.05 | $101K | 130,711 |
| 2024-02-20 | SCANGOS GEORGE A Director | Sale 10b5-1 | −16,872 | $10.22 | $172K | 140,739 |
| 2024-02-16 | SCANGOS GEORGE A Director | Sale 10b5-1 | −10,878 | $10.24 | $111K | 157,611 |
| 2024-02-16 | Pang Phillip EVP & Chief Medical Officer | Sale 10b5-1 | −3,321 | $10.24 | $34K | 264,679 |
| 2024-01-02 | Pang Phillip EVP & Chief Medical Officer | Option exercise | +18,833 | $0.86 | $16K | 206,833 |
| 2024-01-02 | Pang Phillip EVP & Chief Medical Officer | Option exercise | +13,576 | $1.58 | $21K | 220,409 |
| 2024-01-02 | Pang Phillip EVP & Chief Medical Officer | Option exercise | +47,591 | $1.53 | $73K | 268,000 |
| 2024-01-02 | Pang Phillip EVP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −18,833 | $0.86 | $16K | 0 |
| 2024-01-02 | Pang Phillip EVP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −13,576 | $1.58 | $21K | 0 |
| 2024-01-02 | Pang Phillip EVP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −47,591 | $1.53 | $73K | 0 |
| 2023-10-19 | MORE ROBERT J Director | Other disposition | −6,405 | 38,683 | ||
| 2023-10-19 | MORE ROBERT J Director | Other acquisition | +6,405 | 495,890 |
Page 10 of 54 · 1,063 trades